ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04371	Apelin signaling pathway	7/23	177/7206	8.42659377062e-07
ko04068	FoxO signaling pathway	6/23	167/7206	1.03073208959e-05
ko05224	Breast cancer	6/23	174/7206	1.3046941904e-05
ko01522	Endocrine resistance	5/23	124/7206	3.65276369727e-05
ko05230	Central carbon metabolism in cancer	4/23	81/7206	0.000111518876012
ko04320	Dorso-ventral axis formation	3/23	31/7206	0.000120464155969
ko04550	Signaling pathways regulating pluripotency of stem cells	5/23	165/7206	0.000142692527427
ko05206	MicroRNAs in cancer	5/23	177/7206	0.000198470322743
ko01521	EGFR tyrosine kinase inhibitor resistance	4/23	106/7206	0.000315811728689
ko05215	Prostate cancer	4/23	111/7206	0.000376729092892
ko05219	Bladder cancer	3/23	48/7206	0.000447403822267
ko05200	Pathways in cancer	7/23	492/7206	0.00062061089188
ko05213	Endometrial cancer	3/23	62/7206	0.000950213106839
ko05221	Acute myeloid leukemia	3/23	63/7206	0.000995649902805
ko04151	PI3K-Akt signaling pathway	6/23	390/7206	0.00111068085156
ko05223	Non-small cell lung cancer	3/23	66/7206	0.00114017380593
ko04015	Rap1 signaling pathway	5/23	278/7206	0.00156497074846
ko04014	Ras signaling pathway	5/23	279/7206	0.00159016011285
ko05214	Glioma	3/23	79/7206	0.00191779793407
ko04218	Cellular senescence	4/23	177/7206	0.00216165113276
ko05212	Pancreatic cancer	3/23	83/7206	0.00220981124444
ko05218	Melanoma	3/23	85/7206	0.00236563979672
ko04917	Prolactin signaling pathway	3/23	87/7206	0.00252815198101
ko04010	MAPK signaling pathway	5/23	321/7206	0.00294689738236
ko04921	Oxytocin signaling pathway	4/23	209/7206	0.00394712945175
ko04012	ErbB signaling pathway	3/23	109/7206	0.00478350767973
ko05216	Thyroid cancer	2/23	34/7206	0.00513819241579
ko04912	GnRH signaling pathway	3/23	122/7206	0.00654809936849
ko04540	Gap junction	3/23	128/7206	0.00747763603423
ko04915	Estrogen signaling pathway	3/23	131/7206	0.00797040901996
ko05231	Choline metabolism in cancer	3/23	134/7206	0.00848209516236
ko04933	AGE-RAGE signaling pathway in diabetic complications	3/23	135/7206	0.00865688996413
ko04810	Regulation of actin cytoskeleton	4/23	264/7206	0.00899587592125
ko05205	Proteoglycans in cancer	4/23	271/7206	0.0098471030547
ko04916	Melanogenesis	3/23	142/7206	0.00994032868288
ko04919	Thyroid hormone signaling pathway	3/23	143/7206	0.0101322988172
ko05166	HTLV-I infection	4/23	292/7206	0.0127144394194
ko04330	Notch signaling pathway	2/23	62/7206	0.0164073783629
ko04910	Insulin signaling pathway	3/23	172/7206	0.0166622748628
ko04310	Wnt signaling pathway	3/23	181/7206	0.0190752937649
ko04150	mTOR signaling pathway	3/23	184/7206	0.0199209635589
ko04390	Hippo signaling pathway	3/23	188/7206	0.0210807942953
ko04214	Apoptosis - fly	2/23	72/7206	0.0217540319521
ko04072	Phospholipase D signaling pathway	3/23	197/7206	0.0238256299012
ko04370	VEGF signaling pathway	2/23	77/7206	0.0246645782404
ko04664	Fc epsilon RI signaling pathway	2/23	77/7206	0.0246645782404
ko04730	Long-term depression	2/23	78/7206	0.0252649931711
ko04610	Complement and coagulation cascades	2/23	79/7206	0.025871413827
ko05220	Chronic myeloid leukemia	2/23	85/7206	0.029633782772
ko04213	Longevity regulating pathway - multiple species	2/23	86/7206	0.0302811096423
ko05210	Colorectal cancer	2/23	86/7206	0.0302811096423
ko04662	B cell receptor signaling pathway	2/23	88/7206	0.0315927756434
ko04360	Axon guidance	3/23	233/7206	0.0366804179967
ko05211	Renal cell carcinoma	2/23	96/7206	0.0370605434894
ko04658	Th1 and Th2 cell differentiation	2/23	96/7206	0.0370605434894
ko04650	Natural killer cell mediated cytotoxicity	2/23	97/7206	0.0377682529746
ko04720	Long-term potentiation	2/23	99/7206	0.039199413262
ko04520	Adherens junction	2/23	103/7206	0.0421236535889